6185 — Cansino Biologics Share News
0.000.00%
Last trade - 00:00- HK$5.73bn
- HK$4.18bn
- CNY1.06bn
China's CanSino: 'positive' interim data on COVID mRNA vaccine booster trial (updated)
China's CanSino: 'positive' interim data on COVID mRNA vaccine booster trial
Brief: JPMorgan's Long Position In H-Shares Of CanSino Biologics Rises To 7.33% - HKEX Filing
Brief: JPMorgan's Long Position In H-Shares Of Cansino Biologics Falls To 6.93% - HKEX Filing
Brief: Corrected-CanSino's Vaccines Recommended As Second Booster Shot
Brief: CanSino Biologics' COVID Vaccines Recommended As Booster Shots
CanSino jumps on inclusion in China's second COVID-19 vaccine booster shots
Brief: JPMorgan's Long Position In H-Shares Of CanSino Falls To 6.96% - HKEX Filing
Brief: JPMorgan's Long Position In H-Shares Of CanSino Rises To 8.25% - HKEX Filing
Brief: Goldman Sachs Group Inc's Long Position In H-Shares Of CanSino Rises To 5.11% - HKEX Filing
CanSino Biologics leads slide in vaccine makers as China eases COVID curbs
Brief: CanSino Biologics Conducts A-Share Buyback
Brief: JPMorgan's Long Position In H-Shares Of CanSino Falls To 7.25% - HKEX Filing
CanSino jumps after update on inhalable COVID vaccine output capacity
Brief: JPMorgan's Long Position In H-Shares Of CanSino Rises To 8.34% - HKEX Filing
Brief: CanSino's Inhalable COVID Vaccines Available In Beijing
Brief: CanSino's Inhalable COVID Vaccines Gets Approval For Emergency Use In Morocco
CanSino Biologics' HK shares rise on inhalable COVID vaccine launch in Tianjin
Brief: Capital Group Companies Inc's Long Position In H-Shares Of CanSino Falls To 17.99% - HKEX Filing